From CRISPR bench to bedside: Clinical pharmacology, pharmacogenomics, and safety lessons after the first genome-editing approvals
CRISPR-Cas9 genome editing, a Nobel Prize-winning technology discovered in 2012, has transitioned from labo-ratory tool to clinical therapy with the 2023–2024 approvals